We are currently working to identify the lead investigator for our Risk-Adaptive Therapy for Pediatric Oncology project. Over the coming weeks we expect to confirm a project leader and give this initiative a new momentum, as we begin assembling an international clinical and research team around it.
Today OncoHelper AI is launching a new project on curable hereditary anemias in children, a field where data from high risk, low and middle income regions is still very limited. We are now forming the core clinical and research team for this work and are open to collaborators. As soon as the team is in place, the project will move into full development.
Today, the core team for the PARP1-inhibitor project has been reassembled. This group includes the specialists who originally launched the initiative and know its foundations well. With the primary team now in place, the project is moving into its next phase of full-scale development.
Starting this week, we will be posting weekly updates on this project and its progress. Each update will highlight what has changed in the project sections, the steps we have taken, and what comes next, so you can follow the work in real time. Today we have refreshed several parts of the project to reflect its current status. We are committed to keeping this weekly update cycle, so that our donors and partners always have a clear and confident view of how the project is moving forward.
Update: Starting February 1, 2026, we will publish one project update every two weeks.
Starting this week, we will be posting weekly updates on this project and its progress. Each update will highlight what has changed in the project sections, the steps we have taken, and what comes next, so you can follow the work in real time. Today we have refreshed several parts of the project to reflect its current status. We are committed to keeping this weekly update cycle, so that our donors and partners always have a clear and confident view of how the project is moving forward.
